by Annabel Sedgwick
Share
by Annabel Sedgwick
Share
A report from the International Agency for Research on Cancer1 recently classified TiO2 as ‘possibly carcinogenic to humans’ by inhalation and similarly, the European Chemicals Agency2 recommended TiO2 be classified as a category 2 carcinogen (suspected of causing cancer).
In contrast, antimicrobial technologies from Microban International are based on SilverShield®, the first patented antimicrobial solution for ceramic products, which is far safer and superior, posing no additional risk of exposure to potentially carcinogenic compounds and harmful free radicals during tile installation. In addition, unlike TiO2, these chemistries do not need light to activate their protective action. Microban silver-based antimicrobial ceramic technologies are US EPA registered and EU BPR notified, providing consumers with safe, sustainable and environmentally friendly tiles that offer cleaner, fresher, and better protected living spaces without compromising on look or quality.
Giorgio Rimini, Managing Director EMEA at Microban International, added: “With our partners on board, we have been able to combine our collective knowledge to equip homes and places of business with antimicrobial tiles that are simultaneously protective and stunning!”
To explore the safety concerns related to the use of TiO2 in indoor ceramic applications, read the latest article from Dr. Ivan Ong, Vice President of Research and Development, and Tara Conley, Director of Regulatory Affairs at Microban International, at https://bit.ly/3ewyFSv.
- https://monographs.iarc.who.int/wp-content/uploads/2018/06/TR42-Full.pdf
- https://echa.europa.eu/documents/10162/594bf0e6-8789-4499-b9ba-59752f4eafab
About Microban International
Microban International is a global specialist in antimicrobial, odor control, smart surface and disinfection technologies. Our proactive systems keep products cleaner, and control odors better by preventing problems before they start. For more information, please visit www.microban.com.
Microban® International – the global leader in antimicrobial additives and odor control solutions – has released a statement discrediting unwarranted claims about the safety and efficacy of antimicrobial technologies. This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning. Making a clear distinction between public health and non-public health claims, Microban has explained the advantages of incorporating its antimicrobial additives into
Anion dysregulation is seen in numerous diseases, from cystic fibrosis and chronic pain, to autism and cancer. Researchers at the University of Dallas are investigating anion transport in vivo, developing novel tools to help analyze the effects of both normal and aberrant anion regulation at the molecular level, and are using INTEGRA’s PIPETBOY acu 2 to streamline their cell
June Medical is one of 48 organisations to be recognised for their excellence in innovation in this year’s Queen’s Awards for Enterprise. Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country – rewarding only the most outstanding achievements – with winning businesses able to use the esteemed
INTEGRA Biosciences’ VIAFLO electronic pipettes are helping denovoMATRIX in Dresden, Germany, to produce modular, biomimetic coatings for cell culture plasticware that can be tailored to recreate a large variety of conditions for testing adherent cell cultures. Chief Scientific Officer Dr Richard Wetzel explained: “We have developed a range of pre-coated cell culture plasticware – screenMATRIX and myMATRIX – and